Bone marrow endothelial progenitors are defective in systemic sclerosis

Nicoletta Del Papa(University of Milan), Giorgio Lambertenghi‐Deliliers(Ospedale Maggiore), Cinzia Scavullo(Azienda Ospedaliera Fatebenefratelli e Oftalmico), Michela Cortiana(University of Milan), Chiara Borsotti(Azienda Ospedaliera Fatebenefratelli e Oftalmico), Armando Gabrielli(Marche Polytechnic University), Agostino Cortelezzi(Istituti di Ricovero e Cura a Carattere Scientifico), Paolo Fraticelli(Marche Polytechnic University), Davide Soligo(University of Milan), D.P. Comina(University of Milan), Wanda Maglione(University of Milan), Claudio Vitali, N. Quirici(Azienda Ospedaliera Fatebenefratelli e Oftalmico)
Arthritis & Rheumatism
July 25, 2006
10.1002/art.22035
Cited by 165

Related Papers

Autologous Hematopoietic Stem Cell Transplantation vs Intravenous Pulse Cyclophosphamide in Diffuse Cutaneous Systemic Sclerosis
|JAMA|2014|739
Improved risk classification for risk-specific therapy based on the molecular study of minimal residual disease (MRD) in adult acute lymphoblastic leukemia (ALL)
|Blood|2009|433
Effects and safety of rituximab in systemic sclerosis: an analysis from the European Scleroderma Trial and Research (EUSTAR) group
|Annals of the Rheumatic Diseases|2014|432
Improved Outcomes With Retinoic Acid and Arsenic Trioxide Compared With Retinoic Acid and Chemotherapy in Non–High-Risk Acute Promyelocytic Leukemia: Final Results of the Randomized Italian-German APL0406 Trial
|Journal of Clinical Oncology|2016|394
Differentiation and expansion of endothelial cells from human bone marrow CD133<sup>+</sup> cells
|British Journal of Haematology|2001|382